Ep 53 | J&J 340B Rebate Model Follow-Up Discussion
In this episode, Greg and Rob catch up on developments surrounding the J&J 340B rebate proposal, including HRSA’s response. They’ll address some outstanding questions from the recent SpendMend webinar...
23 Sep 202452min
Ep 52 | 340B Smorgasbord - Contract Pharmacy Legislation, ADR, Section 1115 Waiver Days & 340B Rebate Models
In this episode, Greg and Rob are joined by healthcare attorney and 340B veteran Barbara Straub Williams. They cover a variety of topics, including an update on litigation targeting state-level contr...
3 Sep 20241h 15min
Ep 51 | CMS Medicaid Drug Rebate Program & “Covered Outpatient Drug” Definition
In this episode, Greg and Rob are joined by healthcare attorney Todd Nova to discuss a proposed rule change put forth by CMS in 2023 regarding the Medicaid Drug Rebate Program (MDRP), which includes a...
21 Aug 20241h 17min
Ep 50 | 340B Q&A with Hoopii
This is our 50th episode, and it marks the 2 year anniversary of the 340B Unscripted Podcast. To mark the occasion, Greg asks Rob a hodgepodge of 340B-related questions including entity-owned vs contr...
7 Aug 202446min
Ep 49 | HRSA Audit Trends and Manufacturer Audit Activity – Conversation with Emily Cook
In this episode, Greg and Rob have another repeat guest! Healthcare attorney Emily Cook shares some insights gained from the 340B Coalition Summer Conference around recent HRSA audit patterns (08:37)...
22 Jul 20241h 5min
Ep 48 | 2024 Midyear 340B Review - Conversation with Ted Slafsky
In this episode, Greg and Rob gear up for the 340B Summer Coalition conference, and are joined again by Ted Slafsky to discuss various 340B developments from the first half of 2024. They’ll discuss t...
7 Jul 20241h 14min
Ep 47 | Alternate Distribution Models & 340B
In this episode, Greg and Rob are joined by a new SpendMend team member – Nick Gnadt – to discuss considerations around the use of alternate distribution models (ADMs) in the 340B space. They discuss ...
17 Jun 202455min
Ep 46 | Revisiting the Intersection of the IRA Medicare Drug Pricing Program & 340B – Conversation with Jeff Davis
In this episode, Greg and Rob welcome back health care attorney Jeff Davis to catch up on the latest draft guidance published by CMS to address IRA-mandated Medicare drug pricing provisions and impact...
3 Jun 202453min
